Your only mesothelioma treatments news source!
Click on each item to read full story.

 
Mesothelioma Law Firm Creates Website, www.usaep.org, to Help Victims Receive Compensation
read story
Danziger and De Llano, one of the most experienced law firms representing mesothelioma victims, launched a website designed to provide victims with compassionate and qualified legal assistance LOS ANGELES, ...
 
New ‘SMART’ Trial Aims to Test Radiation for Mesothelioma Treatment Complication, According to Surviving Mesothelioma
read story
Doctors in the UK have launched a clinical trial to test radiotherapy as a means of treating or even preventing a serious complication of interventional mesothelioma treatments. (PRWeb January 16, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12445456.htm
 
Study Finds New Radiotherapy Technique More Effective and Safer for Some Mesothelioma Patients, According to Surviving ...
read story
New research suggests that an advanced targeted radiotherapy technique called volumetric modulated arc therapy (VMAT) may beat other types of conformal radiotherapy for certain patients with malignant pleural mesothelioma. (PRWeb January 24, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12464645.htm
 
New Scientific Paper Summarizes Novel Induction Therapies for Mesothelioma, According to Surviving Mesothelioma
read story
Canadian doctors reveal their new radiotherapy protocol for mesothelioma patients and summarize the newest pre-surgical treatments in new report. (PRWeb January 06, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12422034.htm
 
Mesothelioma Symposium Speakers Announced
read story
Last week, the Mesothelioma Applied Research Foundation officially announced the speakers for its 12th annual International Symposium on Malignant Mesothelioma from March 2nd through March 4th of 2015 in Bethesda, Maryland. (PRWeb December 30, 2014) Read the full story at http://www.prweb.com/releases/2014/12/prweb12414523.htm
 
Researchers Say Experimental Drug May be More Effective than Common Mesothelioma Treatment, According to Surviving ...
read story
A Japanese research team says the experimental drug HUHS1015 is more effective at killing mesothelioma cells and causes fewer side effects than one of the most popular mesothelioma chemotherapy drugs. (PRWeb January 08, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12426322.htm
 
Mesothelioma Expert Calls for Public’s Help to Advance Promising Research
read story
Mary Hesdorffer, mesothelioma expert and executive director of the Mesothelioma Applied Research Foundation released an op-ed this week about mesothelioma research progress in the last decade and a half, and the need for help to continue making progress. (PRWeb December 29, 2014) Read the full story at http://www.prweb.com/releases/2014/12/prweb12414446.htm
 
Next-generation sequencing offers insight into how species adapt to climate change
read story
Environmental scientists have a new tool for studying the responses of species to climate change. Next-generation sequencing (NGS) has made it possible to analyze enormous numbers of short pieces of DNA very quickly, and this technology is already revolutionizing the biomedical sciences. The hope is that NGS may prove similarly useful in ecological studies by providing researchers fresh insight ...
 
Stem Cell Therapy Fixes Post-Surgical Airway Abnormality
read story
Title: Stem Cell Therapy Fixes Post-Surgical Airway Abnormality Category: Health News Created: 12/31/2014 12:00:00 AM Last Editorial Review: 1/2/2015 12:00:00 AM
 
EnGeneIC Completes $10 Million Series B Financing Led by U.S. Institutional Investor
read story
NEW YORK and SYDNEY, Jan. 6, 2015 /PRNewswire/ -- EnGeneIC, Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, announced it has completed an oversubscribed $10 million Series B financing.  The round was led by new investor GRT Capital Partners LLC, a Boston-based institution prominent in the ...